Kiniksa Pharmaceuticals International (KNSA) Intangibles (2021 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Intangibles came in at $14.8 million in Q2 2026, down 6.35% YoY from $15.8 million in Q2 2025, and down 1.67% on a QoQ basis from $15.0 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Intangibles (2021 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 6 years of Intangibles data on file, last reported at $14.8 million in Q2 2026.
- Quarterly Intangibles fell 6.35% year-over-year to $14.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $14.8 million (down 6.35% YoY) and the FY2025 annual result came in at $15.2 million, down 23.75% from the prior year.
- Intangibles eased to $14.8 million in Q2 2026, from $15.0 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $20.0 million in Q1 2022 to a low of $14.8 million in Q2 2026.
- A 5-year average of $17.8 million and a median of $17.2 million in 2023 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles changed 0.0% — and 2025, when it declined 23.75%.
- Tracing KNSA's Intangibles over 5 years: stood at $20.0 million in 2022, then changed by 0.0% to $20.0 million in 2023, then changed by 0.0% to $20.0 million in 2024, then declined by 23.75% to $15.2 million in 2025, then slipped by 3.28% to $14.8 million in 2026.
- The last three Intangibles figures came in at $14.8 million (Q2 2026), $15.0 million (Q1 2026), and $15.2 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.12 Bn |
| 10 | Kiniksa Pharmaceuticals International | 6.09 Bn | 5.57 Bn | 220.03 Mn | 14.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.75 Mn |
| Mar 31, 2026 | 15.00 Mn |
| Dec 31, 2025 | 15.25 Mn |
| Sep 30, 2025 | 15.50 Mn |
| Jun 30, 2025 | 15.75 Mn |
| Mar 31, 2025 | 16.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | 16.50 Mn |
| Jun 30, 2024 | 16.75 Mn |
| Mar 31, 2024 | 17.00 Mn |
| Dec 31, 2023 | 20.00 Mn |
| Sep 30, 2023 | 17.50 Mn |
| Jun 30, 2023 | 20.00 Mn |
| Mar 31, 2023 | 20.00 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 20.00 Mn |
| Jun 30, 2022 | 20.00 Mn |
| Mar 31, 2022 | 20.00 Mn |
| Dec 31, 2021 | 20.00 Mn |
| Sep 30, 2021 | 20.00 Mn |